Veinrib Gadi 4
4 · Eloxx Pharmaceuticals, Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
Veinrib Gadi
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-19+20,000→ 20,000 totalExercise: $1.48Exp: 2031-05-19→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 19, 2022 (the "Cliff Vesting Date"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.